1 |
20-Jun-15 |
FRANCE |
EP-Y0000156-TRAMADOL IMPURITY A-(25MG)-(PHARMACEUTICAL REFERENCE STANDARD)1NOS |
25 |
MGS |
278.75 |
6968.81 |
Bangalore ICD |
2 |
20-Jun-15 |
ITALY |
URSODEOXYCHOLIC ACID |
500 |
KGS |
28875.09 |
14437543.48 |
Sahar Air Cargo ACC |
3 |
20-Jun-15 |
GERMANY |
GLYCOLIC ACID 2X100GMS |
2 |
PCS |
2079.09 |
4158.19 |
Sahar Air Cargo ACC |
4 |
20-Jun-15 |
GERMANY |
GLYCOLIC ACID 4X250GMS |
4 |
PCS |
945.52 |
3782.06 |
Sahar Air Cargo ACC |
5 |
19-Jun-15 |
BRAZIL |
MIXTURE OF BILE ACIDS |
39750 |
KGS |
340.07 |
13517663.25 |
Chennai Sea |
6 |
19-Jun-15 |
BELGIUM |
154511000 GLYCOLIC ACID,99%(100GR) (FOR LABORATORY USE) |
2 |
NOS |
1286.34 |
2572.67 |
Bangalore ACC |
7 |
19-Jun-15 |
FRANCE |
EP-Y0000423_SALMETEROL XINAFOATE FOR SYSTEM SUITABILITY (25 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (4NOS) |
100 |
MGS |
241.35 |
24134.76 |
Bangalore ACC |
8 |
19-Jun-15 |
FRANCE |
EP-D0350000_N-DEMETHYLERYTHROMYCIN A (15 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
30 |
MGS |
402.25 |
12067.38 |
Bangalore ACC |
9 |
19-Jun-15 |
BELGIUM |
154511000 GLYCOLIC ACID,99%(100GR) (FOR LABORATORY USE) |
2 |
NOS |
1343.94 |
2687.87 |
Bangalore ACC |
10 |
19-Jun-15 |
BELGIUM |
125252500- DL-MALIC ACID, 99+% (250GR) (FOR LABORATORY USE) |
1 |
NOS |
851.32 |
851.32 |
Bangalore ACC |
11 |
18-Jun-15 |
SINGAPORE |
ETH-3-HYDROXY BUTY - FOR ANALYSIS PURPOSE |
1 |
KGS |
2743.26 |
2743.26 |
Chennai Air Cargo ACC |
12 |
18-Jun-15 |
BRAZIL |
MIXTURE OF BILE ACIDS |
18750 |
KGS |
340.07 |
6376256.25 |
Chennai Sea |
13 |
17-Jun-15 |
ITALY |
3A,7A-DIHYDROXY,5B-CHOLAN,,24-OIC ACID (TECHNICAL GRADE) |
15181 |
KGS |
5186.02 |
78728996.19 |
Chennai Sea |
14 |
17-Jun-15 |
BRAZIL |
MIXTURE OF BILE ACIDS |
39750 |
KGS |
340.07 |
13517663.25 |
Chennai Sea |
15 |
16-Jun-15 |
KOREA,REPUBLIC OF |
URSODEOXYCHOLIC ACID BP (LIST 3 SL NO-83) |
500 |
KGS |
21123.39 |
10561696.25 |
Kolkata ACC |
16 |
16-Jun-15 |
UNITED STATES |
GLYCOLIC ACID 100G |
1 |
BTL |
5178.66 |
5178.66 |
Sahar Air Cargo ACC |
17 |
18-Jun-15 |
UNITED STATES |
USP-1642857_TACROLIMUS SYSTEM SUITABILITY MIXTURE (10 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
20 |
MGS |
4366.3 |
87325.94 |
Bangalore ACC |
18 |
18-Jun-15 |
UNITED STATES |
USP-1546707_HIGH DENSITY POLYETHYLENE (3 STRIPS) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
3 |
NOS |
3991.3 |
11973.9 |
Bangalore ACC |
19 |
18-Jun-15 |
UNITED STATES |
USP-1374907_MALTITOL (200 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
200 |
MGS |
59.87 |
11973.9 |
Bangalore ACC |
20 |
18-Jun-15 |
UNITED STATES |
USP-1367005_LINCOMYCIN HYDROCHLORIDE (200 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
200 |
MGS |
59.87 |
11973.9 |
Bangalore ACC |
21 |
18-Jun-15 |
UNITED STATES |
USP-1286504_FRUCTOSE (125 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
250 |
MGS |
76.19 |
19046.86 |
Bangalore ACC |
22 |
18-Jun-15 |
UNITED STATES |
USP-1283404_FOSINOPRIL SODIUM (200 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
400 |
MGS |
59.87 |
23947.8 |
Bangalore ACC |
23 |
18-Jun-15 |
UNITED STATES |
USP-1142005_CLOXACILLIN SODIUM (200 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
200 |
MGS |
59.87 |
11973.9 |
Bangalore ACC |
24 |
18-Jun-15 |
UNITED STATES |
USP-1134380_CLARITHROMYCIN RELATED COMPOUND A (50 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
50 |
MGS |
747.39 |
37369.71 |
Bangalore ACC |
25 |
18-Jun-15 |
UNITED STATES |
USP-1134379_CLARITHROMYCIN (100 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
100 |
MGS |
119.74 |
11973.9 |
Bangalore ACC |
26 |
18-Jun-15 |
UNITED STATES |
USP-1134357_CISPLATIN (100 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
100 |
MGS |
119.74 |
11973.9 |
Bangalore ACC |
27 |
18-Jun-15 |
UNITED STATES |
USP-1031503_AMOXICILLIN (200 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
200 |
MGS |
59.87 |
11973.9 |
Bangalore ACC |
28 |
18-Jun-15 |
UNITED STATES |
USP-1000829_ABIRATERONE SYSTEM SUITABILITY MIXTURE (20 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
20 |
MGS |
1868.49 |
37369.71 |
Bangalore ACC |
29 |
18-Jun-15 |
UNITED STATES |
USP-1286005_FOLIC ACID (500 MG) - (PHARMACEUTICAL REFERENCE STANDARD)- (1NOS) |
500 |
MGS |
23.94 |
11969.03 |
Bangalore ACC |
30 |
18-Jun-15 |
UNITED STATES |
USP-1271733_FLUCONAZOLE RELATED COMPOUND C (10 MG) - (PHARMACEUTICAL REFERENCE STANDARD)- (1NOS) |
10 |
MGS |
3735.45 |
37354.52 |
Bangalore ACC |
31 |
18-Jun-15 |
UNITED STATES |
USP-1604202_RIFAMPIN QUINONE (25 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
50 |
MGS |
1496.28 |
74813.89 |
Bangalore ACC |
32 |
18-Jun-15 |
UNITED STATES |
USP-1554192_PRAVASTATIN 1,1,3,3-TETRAMETHYLBUTYLAMINE (200 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (10NOS) |
2000 |
MGS |
64.39 |
128778 |
Bangalore ACC |
33 |
18-Jun-15 |
UNITED STATES |
USP-1417113_INDOMETHACIN RELATED COMPOUND A (25 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (3NOS) |
75 |
MGS |
1496.28 |
112220.83 |
Bangalore ACC |
34 |
18-Jun-15 |
UNITED STATES |
USP-1370702_LOXAPINE SUCCINATE (125 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
250 |
MGS |
76.26 |
19065.83 |
Bangalore ACC |
35 |
18-Jun-15 |
UNITED STATES |
USP-1226003_DOXYCYCLINE HYCLATE (200 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
400 |
MGS |
59.93 |
23971.66 |
Bangalore ACC |
36 |
18-Jun-15 |
UNITED STATES |
USP-1112423_INDOMETHACIN RELATED COMPOUND B (25 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (3NOS) |
75 |
MGS |
1496.28 |
112220.83 |
Bangalore ACC |
37 |
18-Jun-15 |
UNITED STATES |
USP-1078267_BUDESONIDE RELATED COMPOUND G (25 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
50 |
MGS |
1496.28 |
74813.89 |
Bangalore ACC |
38 |
17-Jun-15 |
FRANCE |
EP-Y0001635_DICLOFENAC FOR SYSTEM SUITABILITY (1.002 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
2.004 |
MGS |
6025.73 |
12075.57 |
Bangalore ACC |
39 |
17-Jun-15 |
FRANCE |
EP-Y0001460_ACETYLSALICYLIC ACID FOR PEAK IDENTIFICATION (10.3 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
20.6 |
MGS |
586.19 |
12075.57 |
Bangalore ACC |
40 |
17-Jun-15 |
FRANCE |
EP-Y0001296_NORTRIPTYLINE FOR SYSTEM SUITABILITY (20 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
20 |
MGS |
301.89 |
6037.79 |
Bangalore ACC |
41 |
17-Jun-15 |
FRANCE |
EP-Y0001222_FOSCARNET IMPURITY D (50 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
50 |
MGS |
120.76 |
6037.79 |
Bangalore ACC |
42 |
17-Jun-15 |
FRANCE |
EP-Y0001114_TENOXICAM IMPURITY MIXTURE (0.0042 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
.0042 |
MGS |
1437569.05 |
6037.79 |
Bangalore ACC |
43 |
17-Jun-15 |
FRANCE |
EP-Y0000370_RISPERIDONE FOR SYSTEM SUITABILITY (20 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
40 |
MGS |
301.89 |
12075.57 |
Bangalore ACC |
44 |
17-Jun-15 |
FRANCE |
EP-Y0000220_ROXITHROMYCIN FOR SYSTEM SUITABILITY (10 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
10 |
MGS |
603.78 |
6037.79 |
Bangalore ACC |
45 |
17-Jun-15 |
FRANCE |
EP-P3650000_PROPYL PARAHYDROXYBENZOATE (150 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (1NOS) |
150 |
MGS |
40.25 |
6037.79 |
Bangalore ACC |
46 |
17-Jun-15 |
FRANCE |
EP-K2000010_KETOPROFEN IMPURITY A (10 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
20 |
MGS |
603.78 |
12075.57 |
Bangalore ACC |
47 |
17-Jun-15 |
FRANCE |
EP-A1200000_ANHYDROTETRACYCLINE HYDROCHLORIDE (15 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
30 |
MGS |
402.52 |
12075.58 |
Bangalore ACC |
48 |
16-Jun-15 |
FRANCE |
EP-Y0001721_ROSUVASTATIN FOR SYSTEM SUITABILITY (15 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (4NOS) |
60 |
MGS |
402.55 |
24152.86 |
Bangalore ACC |
49 |
16-Jun-15 |
FRANCE |
EP-Y0001719_ROSUVASTATIN CALCIUM (100 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (4NOS) |
400 |
MGS |
60.38 |
24152.86 |
Bangalore ACC |
50 |
16-Jun-15 |
FRANCE |
EP-Y0001680_CLINDAMYCIN PHOSPHATE FOR SYSTEM SUITABILITY (10 MG) - (PHARMACEUTICAL REFERENCE STANDARD) - (2NOS) |
20 |
MGS |
603.82 |
12076.43 |
Bangalore ACC |
|